FRM
Fox Run Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,369
| Closed | -$239K | – | 886 |
|
|
2025
Q1 | $239K | Sell |
2,369
-6,020
| -72% | -$607K | 0.04% | 745 |
|
|
2024
Q4 | $749K | Sell |
8,389
-3,373
| -29% | -$301K | 0.14% | 282 |
|
|
2024
Q3 | $986K | Buy |
+11,762
| New | +$986K | 0.22% | 130 |
|
|
2023
Q2 | – | Sell |
-4,455
| Closed | -$223K | – | 707 |
|
|
2023
Q1 | $223K | Buy |
+4,455
| New | +$223K | 0.07% | 496 |
|
|
2022
Q3 | – | Sell |
-20,558
| Closed | -$766K | – | 618 |
|
|
2022
Q2 | $766K | Buy |
20,558
+15,538
| +310% | +$579K | 0.38% | 34 |
|
|
2022
Q1 | $222K | Buy |
+5,020
| New | +$222K | 0.12% | 380 |
|
|
2021
Q4 | – | Sell |
-11,573
| Closed | -$502K | – | 485 |
|
|
2021
Q3 | $502K | Sell |
11,573
-2,048
| -15% | -$88.8K | 0.32% | 78 |
|
|
2021
Q2 | $582K | Buy |
+13,621
| New | +$582K | 0.53% | 22 |
|
|
2020
Q4 | – | Sell |
-6,353
| Closed | -$243K | – | 200 |
|
|
2020
Q3 | $243K | Buy |
6,353
+430
| +7% | +$16.4K | 0.61% | 80 |
|
|
2020
Q2 | $208K | Buy |
+5,923
| New | +$208K | 0.28% | 202 |
|
|
2018
Q2 | – | Sell |
-28,077
| Closed | -$767K | – | 685 |
|
|
2018
Q1 | $767K | Sell |
28,077
-7,123
| -20% | -$195K | 0.19% | 166 |
|
|
2017
Q4 | $873K | Buy |
+35,200
| New | +$873K | 0.26% | 92 |
|
|
2017
Q3 | – | Sell |
-20,200
| Closed | -$560K | – | 676 |
|
|
2017
Q2 | $560K | Buy |
+20,200
| New | +$560K | 0.19% | 186 |
|
|
2017
Q1 | – | Sell |
-40,200
| Closed | -$870K | – | 576 |
|
|
2016
Q4 | $870K | Buy |
+40,200
| New | +$870K | 0.46% | 14 |
|